TD Asset Management
GOSS icon

TD Asset Management’s Gossamer Bio GOSS Stock Holding History

TD Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,453
Closed -$880K – 1320
2024
Q3 		$880K Buy
11,453
+3,434
+43% +$264K ﹤0.01% 1213
2024
Q2 		$578K Buy
8,019
+2,741
+52% +$164K ﹤0.01% 1250
2024
Q1 		$498K Sell
5,278
-1,032
-16% -$90.9K ﹤0.01% 1297
2023
Q4 		$461K Buy
+6,310
New +$373K ﹤0.01% 1311
2023
Q3 		– Sell
-1,189
Closed -$114K – 1425
2023
Q2 		$114K Buy
1,189
+868
+270% +$86.5K ﹤0.01% 1386
2023
Q1 		$32.3K Sell
321
-102
-24% -$15.6K ﹤0.01% 1409
2022
Q4 		$73.3K Buy
+423
New +$279K ﹤0.01% 1417

Other funds holding GOSS

Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.65% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

TD Asset Management's GOSS Position: Q4 2024 in Review

TD Asset Management sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 11,453 shares — an estimated $880K sold.

TD Asset Management first reported a position in GOSS in Q4 2022 and held it in 7 quarters. The position peaked at $880K in Q3 2024. 102 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • TD Asset Management reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • TD Asset Management sold 11,453 Gossamer Bio shares in Q4 2024, an estimated $880K.
  • TD Asset Management first reported a position in Gossamer Bio in Q4 2022 and held it in 7 quarters.
  • TD Asset Management's Gossamer Bio position peaked at $880K in Q3 2024.
  • 102 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.